Literature DB >> 2518846

Review article: antibiotics and the gut.

A D Pithie1, C J Ellis.   

Abstract

Antibiotics have an important place in the management of gastrointestinal disease. Recent studies have demonstrated efficacy in acute bacterial gastroenteritis caused by salmonellae and campylobacteriaceae, shigellae and enterotoxigenic strains of E coli (ETEC). Tetracycline remains effective in cholera. Antibiotic resistance is widespread amongst the enteric pathogens and can quickly spread during epidemics of infective diarrhoeas. It is important that antibiotics are reserved for the treatment of serious infections lest their effectiveness in these conditions be lost. Campylobacter pylori appears to be an important cause of chronic active gastritis and is amenable to treatment with antibiotics and bismuth salts. The role of C. pylori in the pathogenesis of peptic ulcer disease is not yet established but there is mounting evidence that antibiotic treatment will have a place in the treatment of this common condition. The effect of antibiotics on the normal intestinal microflora can have serious consequences. It is a major cause of resistance in urinary tract pathogens, can result in outbreaks of hospital infection with resistant organisms and frequently results in C. difficile associated diarrhoea.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2518846     DOI: 10.1111/j.1365-2036.1989.tb00219.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  3 in total

1.  Antimicrobial resistance of fecal aerobic gram-negative bacilli in different age groups in a community.

Authors:  T Leistevuo; J Leistevuo; M Osterblad; T Arvola; P Toivonen; T Klaukka; A Lehtonen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

2.  Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.

Authors:  Chinyu G Su; Faten Aberra; Gary R Lichtenstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

3.  Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Authors:  I Esposito; A de Leone; G Di Gregorio; S Giaquinto; L de Magistris; A Ferrieri; G Riegler
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.